Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.94 USD
412.00 M USD
5.81 B USD
437.06 M
About SMITH & NEPHEW PLC ORD USD0.20
Sector
Industry
CEO
Deepak S Nath
Website
Headquarters
Watford
Founded
1856
FIGI
BBG000C2W4K5
Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
No news here
Looks like there's nothing to report right now
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
SNN5772776
Smith & Nephew plc 5.4% 20-MAR-2034Yield to maturity
5.59%
Maturity date
Mar 20, 2034
SNN5059246
Smith & Nephew plc 2.032% 14-OCT-2030Yield to maturity
5.29%
Maturity date
Oct 14, 2030
SNN5772775
Smith & Nephew plc 5.15% 20-MAR-2027Yield to maturity
4.73%
Maturity date
Mar 20, 2027
XS253247355
SMITH&NEPHEW 22/29Yield to maturity
2.98%
Maturity date
Oct 11, 2029
See all SNN bonds